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ABSTRACT: There are numerous reported cases of extended spectrum beta lactamases (ESBLs) producing 
Enterobacteriaceae in Nigeria, with little effort done on the molecular detection. Epidemiological studies around the 
world have investigated the prevalence of ESBL-producing enterobacteriaceae and they have seen multiple 
mechanisms of drug-resistance. Our study was designed to detect ESBLs genes such as CTX-M, SHV, and TEM 
using PCR from clinical isolates in a tertiary hospital in Sokoto metropolis. Clinical isolates from the Microbiology 
laboratory of the tertiary hospital was collected for 3 months. These isolates were identified using standard 
microbiological methods. They were tested against 8 antibiotics using the modified Kirby Bauer disc diffusion 
method. Multidrug resistant isolates were screened for ESBL production, and further confirmed by the Double Disc 
Synergy Test (DDST). Genotypic confirmation was carried out using multiplex Polymerase Chain Reaction (PCR). 
A total of 47 isolates made up of 21 E. coli (44.6%), 13 Klebsiella spp (27.6%), 7 Salmonella spp (14.9%), 5 Proteus 
mirabilis (10.6%), and 1 Enterobacter spp (2.1%) were obtained from urine, stool, and wound swab. Out of the 47 
isolates, (45) 95.7% were multidrug resistant. Twenty-five (53.2%) were potential ESBL producers, while only 5 
(20.0%) were confirmed phenotypically using a DDST. PCR results revealed 4 out of 5 of the isolates were possessing 
ESBL genes. It also revealed that 3 isolates co-produce TEM and SHV at 403bp and 293bp respectively. Only 1 
isolate produced CTX-M gene at 569bp.  The prevalence of ESBL production in the Gram negative enterobacteriaceae 
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Polymerase chain reaction (PCR) is a valuable 
technique in the diagnosis of bacterial infection. 
Molecular methods might be superior to bacterial 
culture in providing the etiologic diagnosis 
(Morgenstern et al., 2018). Another advantage of 
bacterial PCR is connected to its broad-range nature 
since rare or unexpected pathogen can be found. A 
comparison to culture results reveals difficulties in 
detecting gram positive species and Mycobacterium 
by PCR (Mirsaeidi et al., 2014). Production of ESBLs 
is one of the most prevalent resistance mechanisms in 
Gram-negative bacilli. Initially, ESBLs were 
predominantly described in K. pneumoniae and E. coli 
strains, but recently the enzymes were found in other 
genera of the Enterobacteriaceae family (Shaikh et 
al., 2015). Extended Spectrum Beta Lactamases 
(ESBLs) in human medicine first came to prominence 
following the introduction of the extended-spectrum 
cephalosporins (Rebbah et al., 2018). In the 1980’s, 
the term was applied to mutants of the already 
common plasmid mediated β-lactamases such as SHV 
and TEM. One of the first detected, which originated 
in France, was TEM-3 ESBL which had been 
presumed to have been selected in the human host 
following the introduction and use of cefotaxine. Both 
of the ‘parent’ genotypes of this β-lactamase genes 
blaTEM-1 blaTEM-2 were widely disseminated 
amongst medically important members of 
Enterobacteriaceae and Acinetobacter spp. and it 
seemed logical (Mendonça, 2009). The extended 
spectrum form of the β-lactamase would become much 
more widely disseminated throughout the world under 
the selective pressure of the use of third generation 
cephalosporins (Ahlstrom et al., 2018). This happened 
to a degree in that particularly some variants of TEM, 
such as TEM-10, TEM-24 and SHV-12, became 
widely distributed, particularly amongst Klebsiella 
.spp. in hospital settings, but never reached high levels 
of prevalence (usually <20%). There also was never a 
significant spread of these genes into the more general 
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environmental and commensally pool of 
Enterobacteriaceae, even in countries where ESBL is 
predominant (Iredell et al., 2016). 
 
Phenotype rates were reported to be very high, such as 
in China and India. The initially named MEN-1 ESBL 
from an E. coli isolate characterized in France from a 
patient in Italy (1990) was found to be identical to 
CTX-M-1 from an E.coli isolated from a child in 
Germany (1989) (Hawkey, 2017) . The objective of 
this paper is the genotypic detection of extended 
spectrum beta lactamases from selected bacterial 
isolates obtained from Specialist Hospital Sokoto, 
Nigeria. 
 
MATERIALS AND METHODS 
Sample Collection: The isolates were obtained from 
the Microbiology laboratory in the Specialist Hospital 
Sokoto and were taken to the department of 
Pharmaceutics and Pharmaceutical Microbiology 
Laboratory Usmanu Danfodiyo University Sokoto for 
further analysis. 
 
 Preliminary Test for ESBL Production: The isolates 
were screened for ESBL production using cefotaxime 
(30µg) and the ceftazidime (30µg) discs as described 
by CLSI (2015). 
 
Confirmatory Test for ESBL Production: 
Confirmation of ESBL phenotype was performed for 
47 clinical samples obtained from blood, urine, stool, 
and saliva by Double Disc Synergy Test (DDST) using 
antibiotic discs containing two 3rd generation 
Cephalosporin (CTZ, 30ug and CTX, 30ug) and 
Augumentin(AMC, 30ug). Using a sterile needle, CTZ 
and CTX were placed at a distance of 20mm center to 
center from AMC on Mueller Hinton Agar. The plates 
were then incubated at 370c for 24 hours after which 
they were examined for an extension of the edge of 
zone of inhibition of antibiotic disc towards the AMC. 
Enhancement of zone of inhibition of either or both the 
CTZ and CTX towards the AMC disc is indicative of 
ESBL production (EUCAST, 2014) 
 
Genotypic detection of ESBL: Isolates preparation: 
The materials used in the preparation was sterilized 
using the autoclave, then the peptone water was 
prepared by weighing 1.275g of solid peptone which 
was dissolved in 50mls distilled water inside a beaker 
of 100ml capacity by stirring on a water bath until it 
completely dissolved. Then it was cover with an 
aluminum foil and was sterilized in the autoclave at 
121oC for 15mins. Then 5mls sterile syringe was used 
to aseptically transfer 5mls of the peptone water into 
five different test tubes and covered. Then the 
inoculums which were stored in the refrigerator was 
aseptically transferred into each of the test tubes 
already labeled with sample 1-5 where 1,3 and 5 are 
Klebsiellas, 2 is Proteus mirabilis, and 4 is E. coli. 
Then they were incubated at 37oC for 24hrs. 
 
DNA Extraction: An overnight suspension of the test 
bacteria was prepared by transferring a loop full of the 
isolates into a test tube containing 2mls of peptone 
water. The suspension was centrifuged at 6000rpm for 
5 minutes then, the supernatant was discarded and the 
sediments (cells) were transferred into a 1.5mls 
microfuge tube. Then, the cells were re suspended in a 
50µl of nuclease free water and the tubes were 
transferred into a water bath and boiled at 95oC for 30 
minutes. Then the tubes were allowed to cool and were 
centrifuged at 13000rpm for 5 minutes at 4oC,then the 
supernatants were transferred to a nuclease free 0.5ml 
microfuge tubes and the extracted DNA were stored at 
-20oC until when required for the PCR (Central 
Research Laboratory , 2018). 
 
Multiplex PCR of ESBL: A total of 25µl PCR reaction 
mix containing 5µl of the DNA template was used. 
12.5µl of Biorad mixer, 4.5µlof nuclease free water 
and 0.5µl each of the following primers were 
multiplexed The PCR primers were transferred to a 
Biorad 9700 thermocycler and subjected to initial 
denaturation at 94oC for 3 minutes. The PCR was 
carried using the procedure below 
 
Table 1. Primer sequences 
Primers Tm Nucleotide Sequence (5’-3’) Size (bp) 
SHV -F 60 CGCCTGTGTATTATCTCCCT  
SHV-R 62 CGAGTAGTCCACCAGATCCT 293 
TEM-F 60 TTTCGTGTCGCCCTTATTCC  
TEM-R 62 ATCGTTGTCAGAAGTAAGTTGG 403 
CTX-M-F 60 CGCTGTTGTTAGGAAGTGTG  
CTX-M-R 62 GGCTGGGTGAAGTAAGTGAC 569 
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DNA Amplification: Amplification was be carried out 
in an Eppendorf thermal cycler, according to the 
following thermal and cycling conditions for the TEM, 
SHV and CTX-M gene. Initial denaturation at 94°C 
for 3 minutes, denaturation at 94°C for 45 seconds of 
35 cycles, annealing at 60°C for 30 sec of 35 cycles, 
extension at 72°C for 3 minutes of 35 cycles and final 
extension at 72°C for 2 minutes (Vincent et al., 2018) 
 
Agarose Gel Electrophoresis: After ensuring that the 
electronic digital balance was calibrated, 1.5g of 
Agarose powder was weighed and dissolved in 100ml 
of distilled water and was transferred into the water 
bath for complete dissolution. Then the molten agar 
was allowed to cool to about 50oC and 5µl of ethidium 
bromide was added and swirled to mix. The gel was 
poured into a wide Biorad gel casting unit, and was 
allowed for 30minutes to solidify and transferred into 
an agarose gel tank and was flooded with 500mls of 
0.5x TBE buffer.  Then 10µl of the standard was 
mixed with a 6x loading dye and loaded in each 
allocated wells. The tank was closed and the 
electrophoresis power pack was programmed to run at 
10volts for 30min. then the gel outcome was viewed 
using Biorad gel imager. The result was obtained with 
reference to the base pairs of both forward and reverse 
base pairs (Westermeier, 2016). 
  
RESULTS AND DISCUSSION  
ESBL Percentage Distribution: The result in fig1 
shows that out of the 47 isolates collected, only 5 were 
confirmed to produce ESBL, showing a prevalence of 
11% in the Specialist Hospital Sokoto. The highest 
prevalence was found in Klebsiella spp (3 out of 5) 
followed by Proteus mirabilis (1 out of 5), and E. coli 
(1 out of 5). 
 
Percentage Distribution of ESBL and Non ESBL 
Producers 
From the result obtained  in fig 2, 80% of the processed 
samples were found  to be positive for ESBL which 
was in line with to Nuhu et al., 2016 who concluded 
that the ESBL producing uro- pathogen in Sokoto 
metropolis was (66%) while  the remaining 20% was 
negative showing a high percentage reliability of the 
phenotypic detection.The result obtained from plate 2 
shows a gel image of the amplified genes in which the 
CTX-M, was amplified at 569bp and happens to be the 
largest, followed by TEM amplified at 403bp, then 
SHV amplified at 293bp. The M was the marker and 
the NC was for the negative control. There was 11% 
prevalence of ESBL obtained in the Specialist 
Hospital Sokoto, which was in line with the 15.4% 
obtained by Tanko et al in 2015 and far from Kaduna 
state that was reported to have confirmed ESBL 
(37.5%) by Shetu et al in 2017 from snacks. 
 




Fig.2 Percentage distribution of ESBL and non ESBL producer for 
TEM, SHV, or CTX-M 
 
 
Plate 2: Gel image of the amplified genes 
 
M: marker, NC= negative control, 1=sample E1, 2= sample E2, 3= 
sample E3, 4= sample E4, 5= sample E5, SHV – 293bp, TEM-
403bp, CTXM- 569bp. E1, E3 and E5 are Klebsiella spp while 
E2=Proteus mirabilis and E4= Escherichia coli 
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Adeluola, et al., 2018 carried a research on the 
detection, inhibition and molecular analysis of 
multidrug resistant aerobic gram-negative clinical 
isolates from a tertiary hospital in Nigeria in which 
they obtained a result of 12% of ESBL genes. The 
remaining 89% were negative which signifies that 
majority of the population sampled were free from the 
ESBL production but a total clearance is expected 
because the 11% can spread over time to the rest of the 
population. From the multiplexed PCR results 
obtained in fig2 the different amplicon size of 293bp 
for SHV-F (CGCCTGTGTATTATCTCCCT), 
SHVR(CGAGTAGTCCACCAGATCCT), 403bp for 
TEM-F(TTTCGTGTCGCCCTTATTCC), and 569bp 
for CTX-M primers for both forward and reverse 
Oligonucleotides was observed that sample 1,2 and 3 
have two bands of amplicons of 293bp and 403bp 
which signifies that the primers that amplified the gene 
for ESBL were SHV and TEM respectively while 
sample 4 has only one band of 569bp which shows that 
it was amplified by CTX-M primer and sample 5 has 
no band signifying that there is no gene coding for 
ESBL or the specific primer that can amplify the gene 
was not used for the experiment, but 80% of the 
isolates where ESBL producers, while 20% of the 
sample which was just 1 was found to be non ESBL 
producer. 
 
Conclusion: The prevalence of ESBLs in the hospital 
samples collected was 11% and there is a high risk of 
it rising to a higher percentage due to the fact that 
patient and health workers could be a medium of 
transferring some of this resistant organism. The 
percentage of the detected ESBL producers was 80% 
which means that the phenotypic methods of 
identification could be reliable. 
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